ABMR	antibody-mediated rejection
BPAR	biopsy-proven acute rejection
CI	confidence interval
CNI	calcineurin inhibitor
dnDSAs	de novo donor-specific HLA antibodies
GN	glomerulonephritis
HLA	human leukocyte antigen(s)
HR	hazard ratio
ITT	intention to treat
KTX	kidney transplantation
MMF	mycophenolate mofetil
MPA	mycophenolic acid
mTORi	mammalian target of rapamycin inhibitor(s)
n.s.	not significant
PRAs	panel-reactive antibodies